Literature DB >> 6065889

Effects of adrenaline on human blood platelets.

D C Mills, G C Roberts.   

Abstract

1. Adrenaline at concentrations too low to cause aggregation of human platelets potentiates the aggregation by adenosine diphosphate. Noradrenaline has the same effect but is less active than adrenaline; isopropylnoradrenaline is inactive or inhibitory.2. The potentiation of adenosine diphosphate by catecholamines is blocked by the adrenergic alpha-receptor antagonists phentolamine and dihydroergotamine but not by 2-halogenoethylamines or by adrenergic beta-receptor antagonists.3. Both the first and second phases of adenosine diphosphate aggregation are potentiated by catecholamines but the second phase more than the first.4. The release from the platelets of adenine nucleotides which is associated with the second phase of aggregation is also increased by adrenaline.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6065889      PMCID: PMC1365609          DOI: 10.1113/jphysiol.1967.sp008369

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  29 in total

1.  EFFECTS OF INORGANIC IONS AND OF PLASMA PROTEINS ON THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  PLATELET CHANGES AFTER ADRENALINE INFUSIONS WITH AND WITHOUT ADRENALINE BLOCKERS.

Authors:  P D MCCLURE; G I INGRAM; R V JONES
Journal:  Thromb Diath Haemorrh       Date:  1965-03-15

3.  PLATELET CLUMPING IN VITRO.

Authors:  J R MITCHELL; A A SHARP
Journal:  Br J Haematol       Date:  1964-01       Impact factor: 6.998

4.  COLLAGEN-INDUCED RELEASE OF ADENOSINE DIPHOSPHATE FROM BLOOD PLATELETS INCUBATED WITH RADIOACTIVE PHOSPHATE IN VITRO.

Authors:  H HOLMSEN
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

5.  Changes in coagulability of the blood during various phases of ischaemic heart-disease.

Authors:  L McDONALD; M EDGILL
Journal:  Lancet       Date:  1959-05-30       Impact factor: 79.321

6.  Plasma catechol amine concentrations in myocardial infarction and angina pectoris.

Authors:  P C GAZES; J A RICHARDSON; E F WOODS
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

7.  The mechanism of platelet aggregation in relation to hemostasis.

Authors:  R KASER-GLANZMANN; E F LUSCHER
Journal:  Thromb Diath Haemorrh       Date:  1962-07-15

8.  Potentiation of platelet aggregation by adrenaline.

Authors:  G V Born; D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

9.  Aggregation of guinea-pig platelets by adenosine diphosphate.

Authors:  J W Constantine
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

10.  A COMPARISON OF PLATELET AGGREGATION PRODUCED BY SEVEN COMPOUNDS AND A COMPARISON OF THEIR INHIBITORS.

Authors:  J R O'BRIEN
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

View more
  51 in total

1.  Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.

Authors:  D M Vanags; S E Rodgers; E M Duncan; J V Lloyd; F Bochner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Binding of [3H]-dihydroergocryptine to alpha-adrenoceptors on intact human platelets [proceedings].

Authors:  D J Boullin; J M Elliott
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

3.  Platelet in vitro responses to urapidil and prazosin.

Authors:  C C Smith; D J Betteridge; B N Prichard
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.

Authors:  R W Alexander; B Cooper; R I Handin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

5.  Association between mean platelet volume and autonomic nervous system functions: Increased mean platelet volume reflects sympathetic overactivity.

Authors:  Ozcan Ozdemir; Mustafa Soylu; Omer Alyan; Bilal Geyik; Ahmet Duran Demir; Dursun Aras; Gökhan Cihan; Göksel Cagirci; Fehmi Kacmaz; Yücel Balbay; Hatice Sasmaz; Sule Korkmaz
Journal:  Exp Clin Cardiol       Date:  2004

6.  Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit.

Authors:  M Emerson; W Paul; C P Page
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

7.  Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.

Authors:  H Holmsen; H J Day; C A Setkowsky
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

8.  Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.

Authors:  B B Vargaftig; M Chignard
Journal:  Agents Actions       Date:  1975-05

9.  The interaction of bovine factor VIII with human platelets.

Authors:  E P Kirby; D C Mills
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

Authors:  M A Pfeifer; K Ward; T Malpass; J Stratton; J Halter; M Evans; H Beiter; L A Harker; D Porte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.